These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8224935)

  • 21. Liposome-encapsulated 5-fluorouracil in the treatment of proliferative vitreoretinopathy.
    Joondeph BC; Peyman GA; Khoobehi B; Yue BY
    Ophthalmic Surg; 1988 Apr; 19(4):252-6. PubMed ID: 3362494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of erosive vitreoretinopathy.
    Kyung SE; Chang MH; Ji JY
    Korean J Ophthalmol; 2002 Jun; 16(1):47-51. PubMed ID: 12162518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinal toxicity of amphotericin B in vitrectomised versus non-vitrectomised eyes.
    Baldinger J; Doft BH; Burns SA; Johnson B
    Br J Ophthalmol; 1986 Sep; 70(9):657-61. PubMed ID: 3756121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infliximab exerts a dose-dependent effect on retinal safety in the albino rabbit.
    Zayit-Soudry S; Vainer I; Zemel E; Mimouni M; Rabena M; Pieramici DJ; Perlman I; Loewenstein A
    Doc Ophthalmol; 2017 Dec; 135(3):175-185. PubMed ID: 28825191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of experimental proliferative vitreoretinopathy with a biodegradable intravitreal implant for the sustained release of fluorouracil.
    Rubsamen PE; Davis PA; Hernandez E; O'Grady GE; Cousins SW
    Arch Ophthalmol; 1994 Mar; 112(3):407-13. PubMed ID: 8129669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experiment of vitreous liquefaction induced by C3F8.
    Wang J; Li Q
    Pak J Pharm Sci; 2017 Jan; 30(1 Suppl):281-287. PubMed ID: 28625955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Daunomycin and silicone oil for the treatment of proliferative vitreoretinopathy.
    Wiedemann P; Leinung C; Hilgers RD; Heimann K
    Graefes Arch Clin Exp Ophthalmol; 1991; 229(2):150-2. PubMed ID: 2044976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of experimental proliferative vitreoretinopathy in rabbits].
    Kuriyama S; Ohuchi T; Okada M; Yamakawa R; Yoshimura N; Honda Y
    Nippon Ganka Gakkai Zasshi; 1990 Sep; 94(9):792-8. PubMed ID: 2248164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ocular pigmentation protects the rabbit retina from gentamicin-induced toxicity.
    Zemel E; Loewenstein A; Lei B; Lazar M; Perlman I
    Invest Ophthalmol Vis Sci; 1995 Aug; 36(9):1875-84. PubMed ID: 7635661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative assessment of growth stimulating activity of the vitreous during PVR.
    Yang CM; Cousins SW
    Invest Ophthalmol Vis Sci; 1992 Jul; 33(8):2436-42. PubMed ID: 1634341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of radiation therapy for experimental proliferative vitreoretinopathy in rabbits.
    Kuriyama S; Ohuchi T; Yoshimura N; Honda Y; Hiraoka M; Abe M
    Graefes Arch Clin Exp Ophthalmol; 1990; 228(6):552-5. PubMed ID: 2265771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morphological and functional damage of the retina caused by intravitreous indocyanine green in rat eyes.
    Enaida H; Sakamoto T; Hisatomi T; Goto Y; Ishibashi T
    Graefes Arch Clin Exp Ophthalmol; 2002 Mar; 240(3):209-13. PubMed ID: 11935278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of triamcinolone acetonide on a refined experimental model of proliferative vitreoretinopathy.
    Chandler DB; Rozakis G; de Juan E; Machemer R
    Am J Ophthalmol; 1985 Jun; 99(6):686-90. PubMed ID: 2409802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiproliferative effect of mitomycin C on experimental proliferative vitreoretinopathy in rabbits.
    Yu HG; Chung H
    Korean J Ophthalmol; 1997 Dec; 11(2):98-105. PubMed ID: 9510652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraocular daunorubicin for the treatment and prophylaxis of traumatic proliferative vitreoretinopathy.
    Wiedemann P; Lemmen K; Schmiedl R; Heimann K
    Am J Ophthalmol; 1987 Jul; 104(1):10-4. PubMed ID: 3605276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retinal tolerance to intravitreal perfluoroethylcyclohexane liquid in the rabbit.
    Sparrow JR; Matthews GP; Iwamoto T; Ross R; Gershbein A; Chang S
    Retina; 1993; 13(1):56-62. PubMed ID: 8460281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the question of the origin of macrophages in the retina and the vitreous following photocoagulation (autoradiographic investigations by means of 3H-thymidine).
    Gloor BP
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1974 May; 190(3):183-94. PubMed ID: 4546164
    [No Abstract]   [Full Text] [Related]  

  • 38. Transferrin-ricin A chain toxin limits the development of experimental proliferative vitreoretinopathy.
    Handa JT; Keithahn MA; Jaffe GJ
    Exp Eye Res; 1996 Jun; 62(6):689-96. PubMed ID: 8983950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mononuclear phagocytes in proliferative vitreoretinopathy (PVR). A specific role of microglial cells in non-traumatic disease?
    Weller M; Esser P; Heimann K; Wiedemann P
    Eur J Ophthalmol; 1991; 1(4):161-6. PubMed ID: 1821209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Collagen gel contraction by cells associated with proliferative vitreoretinopathy.
    Guidry C; McFarland RJ; Morris R; Witherspoon CD; Hook M
    Invest Ophthalmol Vis Sci; 1992 Jul; 33(8):2429-35. PubMed ID: 1634340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.